Viking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 TrialJuly 31, 2025Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Nears Obesity Drug Breakthrough with Phase 3 VK2735 TrialJuly 31, 2025Yahoo Finance
Ultragenyx Pharmaceutical Inc. (RARE) Gets FDA CRL for UX111, Vows Quick ResubmissionJuly 31, 2025Yahoo Finance
Ultragenyx Pharmaceutical Inc. (RARE) Gets FDA CRL for UX111, Vows Quick ResubmissionJuly 31, 2025Yahoo Finance
Ultragenyx Pharmaceutical Inc. (RARE) Gets FDA CRL for UX111, Vows Quick ResubmissionJuly 31, 2025Yahoo Finance